7/28/2019 Pharmacy Daily for Tue 09 Apr 2013 - Dextropropoxyphene, APC committee, Mildura hospital pharmacy, Guild up

1/3

Tuesday 09 Apr 2013 PHARMACYDAILY.COM.AU

Pharmacy Daily Tuesday 9th April 2013 t 1300 799 220 wwww.pharmacydaily.com.au page 1

Dextropropoxyphene winDi-GesiC and Doloxenew cu b b

Au p u,

c F by h

A App Tbu

(AAT) h c c

dextropopoxyphene should remain

on the Australian Register of

Thpuc G.

I h cu f -

u h

12 months ago (PD 24 N 2011)

wh h Thpuc G

A c cch f Cpx,

Dx, Px D-Gc

c f 01 M 2012.

A h h c w

b TGA w f b

c whch hw h

cpu c c h cc

cy f h h, py

increasing the risk of arrhythmia.

Ap Au, whch upp

D-Gc Dx, c h

TGA h w uy f

ju x p, cb h

qub.

Early last year Aspen applied for

a stay of the suspension from the

ARTG (PD 17 Fb 2012), h

Ju h A App

Tbu u c whch

f h bck h

Thpuc G A.

Th TGA c c

up h c, wh

Ap ubquy uch

further AAT case (PD 13 Sep).

Aspen said as part of that appeal

h h wu b p whu fcy p f f

h c w

from the market.

A h w w f

Fb h y (PD 09 N 12)

h TGA c h h

c u pp pu

fw by h p f h

medicines which would allow them

y h ARTG.

Hw h TGA w

h h pp

would address the safety issues

.

I h c h Tbu

h w c h bh

D-Gc Dx hu h ARTG, ubjc h

p f c

promote the safe use of the drugs.

Th AAT c w

c h c f

cc c xp pu

fw by bh h Thpuc

G A Ap

h cu f wk u

2012, fuh h

Fbuy 2013, cc

u by Ap

yy .

Ap wu p

fuh f h c

h w b p, fuh

cuc phc.

Dc y cu

pcb bh puc

cfuy c

h c, w

cc h Puc

If Cu

Mc If f h

puc, h cpy .

D-Gc cuy b

community pharmacies while info h by f Dx,

whch cuy u f ck, w

b p hy.

38GROUP 2

UPTO

CPD CREDITS

31 May 2 June 2013Connecting practice to patient outcomes

2013

CPExpo

www.psa.org.au/cpexpo

Experience the SmarterPharm differenceNO Joining FeesFREE Monthly Membership Fees*FREE Monthly Catalogues and Distribution*

while enjoying access to market-leading generic offers,

great OTC pricing and discounts and excellent wholesaler

trading terms. *Some conditions apply

Want to find our more? Simply phone 03 9842 2974or visit our website www.smarterpharm.com.au

Are you Ready?Be part of the bigger picture...

Identify Record Report

MedsCheck Services

One software solutionclick here

Subscribeonline now

WIN A PLUNKETTS

PRIZE PACK

Everyday thisweekPDis givingtwo luckyreadersthechanceto win a

Plunketts prize pack, valued atover $26 each.

Each prize pack containsPlunketts Vita-E Natural VitaminE Cream 100g, Plunketts99% Pure Aloe Vera Gel 75gand Plunketts SorboleneConcentrated Moisturiser 100g.

To win, simply be one of thefrst two people to send in the

correct answer to the questionbelow to:comp@pharmacydaily.com.au.

How much Vitamin E is

in every gram of Vita E?

Hint! Visitwww.plunketts.com.au

Congratulations to yesterdayslucky winner, Adeleye Erinle ofBroken Hill Base Hospital.

Three pages todayTODAYs issue ofPharmacy Daily

has three pages of all the latest

uy w, cu u u

Tuy Gu Cu pag two

and the April monthly medicines

up f MIMS pag thr.

Mildura hospital

pharmacy restructurePHARMACisTs working at

Mu B Hp Vc

h b h p

b u, wh

h hp phcy b

outsourced to another company

wh h Ry cp.

Th 146-b hp w bu

by Ry Hh C 2000

p wh h

Vc , up c

Rc Mu B Hp

(RMBH) f u pubc .

Acc RMBH, x

hp phcy Mu

b qu ppy f

h p h w py

pubc hp phcy

p.

Roche Isis dealROCHe has announced a

w c wh US- I

Phcuc p

f Hu, b I

uc (ASO) chy.

Rch w cb ppy

b hu chy wh

ASO h hp h uccfu

treatment would allow systemic

f u

ypc p.

Virility pill fnding

THe Thpuc GA h h

c c pp

wb p -c

Vy P Au.

Th fw cp

bu h puc

which implied it was clinically

p, c c

cu y c.

http://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://traveldaily.com.au/click/redirect.asp?url=http://www.guildlink.com.au/patient-care/guildcare-programs1/5cpa-medication-management/medscheck-services/http://www.traveldaily.com.au/click/redirect.asp?url=http://smarterpharm.com.auhttp://traveldaily.com.au/click/redirect.asp?url=http://www.psa.org.au/cpexpohttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.au

7/28/2019 Pharmacy Daily for Tue 09 Apr 2013 - Dextropropoxyphene, APC committee, Mildura hospital pharmacy, Guild up

2/3

Tuesday 09 Apr 2013 PHARMACYDAILY.COM.AU

Pharmacy Daily Tuesday 9th April 2013 t 1300 799 220 wwww.pharmacydaily.com.au page 2

Workplace Relations

tip: Record keeping

Community pharmacyemployers who engage

employees under federalworkplace relations lawshave a legal responsibility toensure accurate and completetime and wages records are

kept, and pay slips are issuedto each employee. Theserecord-keeping and pay slipobligations are designedto ensure that employees

receive their correct wagesand entitlements.

Maintaining accurateemployment records is notonly required, but also ofreal benet to a pharmacy

businesses.

Documentation justiesemployment actions, fromrecruitment and selection toresignation, retirement or

termination.

Training and developmentand compensation andbenets are parts of employeedocumentation as well.

Maintaining accurate andcomplete documentationsupports human resources

objectives, such as successionplanning and promoting fromwithin.

Employee documentation,when prepared carefully,condentially and accordingto company policies, canreduce the chance oflitigation.

Employee documentationis good business practice andpart of QCPP accreditation.

So make sure those recordsare up to date.

Guld Updat

Click to access Claim form

IMPORTANT: Claims received by Medicare after

14 April 2013 will be rejected.

Pharmacy Practice Incentives (PPI)

The DAAs/Clinical Interventions claim form MUST be

lodged with Medicare between 1-14 April 2013

This Project is funded by the Australian Government Department of Health and Ageing as part

of the Fifth Community Pharmacy Agreement.

DAAs/Clinical Interventions

claim form DUE NOW

Call Shannon Kerr 02 9248 2616shannon@instigo.com.au www.instigo.com.au

WANT THE

BEST LOYALTY

SOLUTION

FOR YOUR

PHARMACY?

Plan B for Plan BGiRLs of all ages in the USA will

b b cc h -c

p, c

by US F Ju whch

u u by h HhScy -h-cu

purchases to those aged 17 and up.

L, u h

b P B, w w

qu pcp f

16 u, wh Ju

Ew K cb h

pu by,

cpcu ub.

Th US FDA h puy

pp f h

f , bu h w u

by Hh Hu Sc

Scy Kh Sbu.

A spokesperson for the

Dp f Juc h

wk w b w, wh

h c

p.

Pharmacist ATM?CONTROVeRsiAL Northern

Ty phc R M

says that the current system of

dispensing medicines in Australia

cu b f uc

ch, f h u

that pharmacists add to their

uppy fuc.

W hc.c

h, M h

phcy uy Au h

uccfuy cqu py

uppy c p f by

h cu.

He said the main issue is that

h qu f h

phc c xpy

money to do anything more than

the simple task of dispensing.

A u by h cu

y hy c h c

h qu f h

Cwh pck up h b...

h ccuby f

h $2 b b p u by h

PBS, M w.

I p f f c

h wb bu h phcy

c - CLiCK HeRe w.

APC committee membersTHe Au Phcy Cuc(APC) h c f ppc

f bhp

f Cuc w

Ex C

Acc C.

U h N R

Acc Sch, APC

is designated as the independent

cc cy f phcy

ch Au u Juy 2018.

Th w Cuc p

b f 01 Juy h y,

wh h pp y f

three year term.

There are also two new roles

b h Ex

C - f y

career pharmacist and the other

f pc c/

psychometrics or assessment.

Tw cc b

b uh f h Acc

C f h c hf f

2013, wh ppc b f-

b by h

.

A w f h p

c c cuy

b h APC wb -

CLiCK HeRe for details.

Appc u by h

Suy 21 Ap 2013, by

to admin@pharmacycouncil.org.au.

Support for McKeonTHe Cpy Hhc

Cuc f Au h

h McK p c

R&D in Australia (PD yy),

wh CHC xcu c WyMw y h

upp h w p

f h h w b

hh-c y wh 10 y.

W upp h Rw

u f b ch

hhc, w f

cuu f cc

ch, Mw .

Rch Au, whch

c f 170 b up

c f hh c

ch Au, y

bck h p, wh Ezbh Fy u Tuy

k ppp c

x h F bu

h p f h

McK w c.

http://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://traveldaily.com.au/click/redirect.php?url=http://theconversation.com/pharmacy-gravy-train-drives-up-the-cost-of-prescription-drugs-10016http://traveldaily.com.au/click/redirect.php?url=http://pharmacycouncil.org.au/content/index.php%3Fid%3D32http://traveldaily.com.au/click/redirect.php?url=http://pharmacycouncil.org.au/content/index.php%3Fid%3D32http://traveldaily.com.au/click/redirect.php?url=http://theconversation.com/pharmacy-gravy-train-drives-up-the-cost-of-prescription-drugs-10016http://www.traveldaily.com.au/click/redirect.asp?url=http://www.instigo.com.au/http://traveldaily.com.au/click/redirect.php?url=http://www.medicareaustralia.gov.au/provider/pbs/fifth-agreement/files/pharmacy-practice-incentive-periodic-payments-application.pdfhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.au

7/28/2019 Pharmacy Daily for Tue 09 Apr 2013 - Dextropropoxyphene, APC committee, Mildura hospital pharmacy, Guild up

3/3

Tuesday 09 April 2013 PHARMACYDAILY.COM.AU

ditorsBuc Pp K M emailinfo@pharmacydaily.com.au advertisingM Hzk email@phcyy.c.u page 3rmacy Daily is a publicaon for health professionals of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain wrien permission from the editor to reproduce any material. While every care has been taken in the

preparaon of Pharmacy Daily no liability can be accepted for errors or omissions Informaon is published in good faith to smulate independent invesgaon of the maers canvassed Responsibility for editorial is taken by Bruce Piper

Students survey suppliers

ABOVe: Rp f

h N Au Phcy

u Ac (NAPSA)

uc uy f uy

uppliers at the recent Pharmacy

Gu f Au APP cfc

h G C.

Th NAPSA Iu A

C pk xhb

h APP hw, wh u

uy b cp

c hw h h

pharmacy profession has a lot of

upp f NAPSA u

h cbu phcy u

c k h wkpc.

APP p ppuy

f b f h NAPSA

xcu fc fc

k p f h

h upc h.

Pcturd b h NAPSA

, f : Ch

Bhw, Luk Vkch,

X A, E P

Mhw T.

Cost Efective Targeted Easy

For details call us today: 1300 799 220

Advertise with us. .

NEW PRODUCTS

AndroForte 2 and AndroForte 5(testosterone) is a transdermaldrug delivery system. It is indicatedas testosterone replacement therapyin symptomatic testosteronedecient males, including conrmed

primary hypogonadism, secondaryhypogonadism and late-onsethypogonadism. Testosterone iscontraindicated in men with known orsuspected carcinoma o the prostate,known or suspected carcinoma o thebreast, known or suspected androgen-dependent neoplasia, nephroticsyndrome or hypercalcaemia. AndroFortehas not been evaluated in women andis contraindicated in pregnancy andwhile breasteeding. The product is notsuitable or children. AndroForte 2 andAndroForte 5 are available as a creamcontaining 20 mg/mL and 50 mg/mLtestosterone respectively in a 50 mLboxed tube.

Caprelsa (vandetanib) is a tyrosinekinase inhibitor that inhibits vascularendothelial growth actor (VEGF)-stimulated VEGF receptor-2 tyrosinekinase. In addition, vandetanib inhibitsepidermal growth actor (EGF)-stimulated EGF receptor tyrosine kinase.Caprelsa is indicated or the treatment o

patients with symptomatic or progressivemedullary thyroid cancer in patientswith unresectable, locally advanced ormetastatic disease. It is contraindicatedin patients with congenital long QTsyndrome. Caprelsa is available as 100mg and 300 mg tablets in blister packs

o 30s.

Extavia (interferon beta-1b (rbe))is indicated or the treatment o patientswith a single clinical event suggestiveo multiple sclerosis (MS) and at leasttwo clinically silent magnetic resonanceimaging (MRI) lesions characteristic oMS, i alternative diagnoses have beenexcluded. It is also indicated or thetreatment o ambulatory patients withrelapsing-remitting MS characterisedby at least two attacks o neurologicdysunction over a two year periodollowed by complete or incompleterecovery. Extavia is also indicated orthe reduction o requency and severityo clinical relapses, and or the slowingo progression o disease in patients

with secondary progressive MS. Extaviais contraindicated in patients with ahistory o hypersensitivity to natural orrecombinant intereron beta. Extavia isavailable as a powder or injection.

Priorix-Tetra (measles (Schwarz),

mumps (Jeryl Lynn, RIT 4385strain), rubella (Wistar RA 27/3)and varicella zoster (OKA strain))is a live virus vaccine or immunisationagainst measles, mumps, rubella andvaricella. Priorix-Tetra is indicatedor active immunisation against

measles, mumps, rubella and varicellarom 9 months o age. Priorix-Tetrais contraindicated in pregnancy. Ivaccination o postpubertal womenoccurs, pregnancy should be avoidedor three months. Priorix-Tetra iscontraindicated in subjects with knownhypersensitivity to neomycin or to anyother component o the vaccine (e.g. eggallergy). Priorix-Tetra is contraindicatedin subjects having shown signso hypersensitivity ater previousadministration o measles, mumps,rubella and/or varicella vaccines.Priorix-Tetra should not be given tosubjects with impaired immune unction.These include patients with primary orsecondary immunodeciencies, those

with untreated malignant disease andthose receiving immunosuppressiveor X-ray therapy or high dosesteroids (equivalent to 2 mg/kg/dayprednisolone). Priorix-Tetra is availableas a powder or injection.

SAFETY RELATED CHANGES

Felodur ER and Plendil ER(felodipine) are now contraindicated inhaemodynamically signicant cardiacvalvular obstruction and dynamic cardiacoutfow obstruction.

The potential risk o apnoea and theneed or respiratory monitoring or48-72 hours should be considered whenadministering the primary immunizationseries o Inanrix IPV (combineddiphtheria, tetanus, acellularpertussis (DTPa) and inactivatedpoliovirus vaccine) to very prematureinants (born 28 weeks o gestation)and particularly or those with a previoushistory o respiratory immaturity.

Pradaxa (dabigatran etexilate) use isnow contraindicated with prosthetic heartvalve replacement.

Adequate diagnostic measures, includingendometrial sampling when indicated,should be undertaken to rule outmalignancy in all cases o undiagnosedpersistent or recurring abnormal vaginalbleeding with the use o Premarin(conjugated oestrogens).

Vend (voriconazole) is now indicatedas prophylaxis in patients who are athigh risk o developing invasive ungal

inections. The indication is based onstudies including patients undergoinghaematopoietic stem cell transplantation.

When using Logynon ED, Levlen ED,Triquilar ED (ethinyloestradiol,levonorgestrel) ollowing a naturalcycle, ollowing rst trimester abortion,ollowing childbirth or second trimesterabortion, when changing rom aprogestogen only method (minipill,injection, implant) or rom a progestogenreleasing intrauterine system (IUS),additional non-hormonal contraceptivemethods are necessary or the next 14days.

When using Diane-35 ED and Juliet-35ED (ethinyloestradiol, cyproteroneacetate) with no preceding hormonalcontraceptive use (in the past month),changing rom a progestogen onlymethod (minipill, injection, implant)or rom a progestogen releasing IUS,ollowing rst trimester abortion, aterchildbirth or a second trimester abortion,

additional non-hormonal contraceptivemethods are necessary or the next 14days.

This list is a summary of only some ofthe changes that have occurred over thelast month. Before prescribing, alwaysrefer to the full product information.

April MIMSMonthly Medicine Update

DISPENSARYCORNER

HeRes some healthy ageing.

A 74-y- p h

UK kp hf by

waterskiing twice a week.

A wh h p f

y pu, P Shh

cy wh h y

c, bcu h b b

for more than 40 years.

Shh h b h

b b cuy k bcu h

f fc f wk.

A h b c

cu f wh xc

- ch u, bu

u h uc f u uc.

The Bristol Postreported the

uuu c whch w 25-y-

A Cy y

cy, u h

h h .

A h w pu c

found that he was listening to a

y f uc kw u

b, h uy

p uy ck .

Pregnancy database

THe Thpuc GA h up

Pcb Mc

Pcy b, whch

p f f hh

professionals planning the medical

f p p

p bc

pregnant.

Th b w c

b ch by c

c , by

cc , bu

cu hpuc

bcu c yp f u usually exempt from pregnancy

c.

B&L FDA approvalBAUsCH + Lb h b

US F Du

A pp f

P (bfc phc

u) 0.07%.

Its a new once daily NSAID

eyedrop indicated for treatment

f pp

uc f cu p fwcataract surgery.

P w b b h

US 1.6 3 b z.

http://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.auhttp://traveldaily.com.au/click/redirect.php?url=http://www.pharmacydaily.com.au